STOCK TITAN

Twist Bioscience insider files to sell 124 vested shares on 10/02/2025

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Form 144 notice for Twist Bioscience Corp (TWST) shows an officer or insider, Dennis H. Cho, proposing to sell 124 common shares on 10/02/2025. Those 124 shares were acquired the prior day, 10/01/2025, by restricted stock vesting as compensation. The filing lists the broker as Fidelity Brokerage Services LLC and indicates an aggregate market value of $3,615.95 for the shares to be sold. The issuer has 60,360,925 shares outstanding per the form. The filing also discloses six prior open-market sales by Dennis H. Cho from 07/02/2025 through 09/22/2025, totaling 2,027 shares and gross proceeds of $54,048.04 across those transactions. The filer certifies no undisclosed material adverse information.

Positive

  • Full disclosure of acquisition method (restricted stock vesting) and sale dates
  • Broker identified (Fidelity Brokerage Services LLC) and aggregate market value provided
  • Prior sales listed with dates and gross proceeds totaling $54,048.04

Negative

  • Insider selling shares (2,027 shares sold in the past three months plus 124 proposed sale)
  • Proposed sale of newly vested shares on 10/02/2025 may increase free float

Insights

Insider sold newly vested shares and previously sold 2,027 shares this quarter.

The filing documents a small planned sale of 124 shares arising from restricted stock vesting on 10/01/2025, to be executed through Fidelity on 10/02/2025. The insider previously sold 2,027 shares between 07/02/2025 and 09/22/2025 for total gross proceeds of $54,048.04, which is fully disclosed in the form.

This is a routine disclosure under Rule 144 and the signer attests there is no undisclosed material adverse information.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the TWST Form 144 disclose about the proposed sale?

The filing discloses a proposed sale of 124 common shares on 10/02/2025 through Fidelity Brokerage Services LLC, with an aggregate market value of $3,615.95.

How were the 124 shares acquired by the seller?

The 124 shares were acquired on 10/01/2025 by restricted stock vesting and the payment nature is listed as compensation.

Who is the selling person named in the Form 144?

The Form 144 identifies Dennis H. Cho as the person who sold shares in prior transactions and is associated with the current notice.

What prior sales by the insider are disclosed in the filing?

Six prior sales by Dennis H. Cho between 07/02/2025 and 09/22/2025 totaling 2,027 shares for gross proceeds of $54,048.04 are listed.

How many shares outstanding does the filing report for TWST?

The filing lists 60,360,925 shares outstanding.
Twist Bioscience

NASDAQ:TWST

TWST Rankings

TWST Latest News

TWST Latest SEC Filings

TWST Stock Data

2.77B
60.26M
1.86%
115.89%
16.96%
Diagnostics & Research
Biological Products, (no Disgnostic Substances)
Link
United States
SOUTH SAN FRANCISCO